These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 39283616)
1. Multilayer Retinal Correspondence of the Structural and Vascular Anomalies in Eyes With Early Macular Telangiectasia Type 2. Krivosic V; Dobbels Z; Duliere C; Zureik A; Tadayoni R; Gaudric A Invest Ophthalmol Vis Sci; 2024 Sep; 65(11):24. PubMed ID: 39283616 [TBL] [Abstract][Full Text] [Related]
2. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography. Pauleikhoff D; Gunnemann F; Book M; Rothaus K Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1381-1392. PubMed ID: 31093765 [TBL] [Abstract][Full Text] [Related]
3. Early-stage macular telangiectasia type 2 vascular abnormalities are associated with interdigitation zone disruption. Ong JX; Zandi R; Fawzi AA PLoS One; 2021; 16(11):e0259811. PubMed ID: 34767582 [TBL] [Abstract][Full Text] [Related]
4. OCT Angiography and Ellipsoid Zone Mapping of Macular Telangiectasia Type 2 From the AVATAR Study. Runkle AP; Kaiser PK; Srivastava SK; Schachat AP; Reese JL; Ehlers JP Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3683-3689. PubMed ID: 28727884 [TBL] [Abstract][Full Text] [Related]
5. Multimodal Imaging of Macular Telangiectasia Type 2: Focus on Vascular Changes Using Optical Coherence Tomography Angiography. Toto L; Di Antonio L; Mastropasqua R; Mattei PA; Carpineto P; Borrelli E; Rispoli M; Lumbroso B; Mastropasqua L Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT268-76. PubMed ID: 27409482 [TBL] [Abstract][Full Text] [Related]
6. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy. Ooto S; Hangai M; Takayama K; Arakawa N; Tsujikawa A; Koizumi H; Oshima S; Yoshimura N Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5541-50. PubMed ID: 21642620 [TBL] [Abstract][Full Text] [Related]
7. OCT of Outer Retinal Hyperreflectivity, Neovascularization, and Pigment in Macular Telangiectasia Type 2. Krivosic V; Lavia C; Aubineau A; Tadayoni R; Gaudric A Ophthalmol Retina; 2021 Jun; 5(6):562-570. PubMed ID: 32956858 [TBL] [Abstract][Full Text] [Related]
8. Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2. Pauleikhoff D; Bonelli R; Dubis AM; Gunnemann F; Rothaus K; Charbel Issa P; Heeren TF; Peto T; Clemons TE; Chew EY; Bird AC; Sallo FB; Acta Ophthalmol; 2019 Nov; 97(7):e998-e1005. PubMed ID: 30968592 [TBL] [Abstract][Full Text] [Related]
9. Predictive multi-imaging biomarkers relevant for visual acuity in idiopathic macular telangiectasis type 1. Guo J; Tang W; Ye X; Wu H; Xu G; Liu W; Zhang Y BMC Ophthalmol; 2018 Mar; 18(1):69. PubMed ID: 29506510 [TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of retinal microvascular changes in macular telangiectasia type 2 using optical coherence tomography angiography. Park YG; Park YH PLoS One; 2020; 15(4):e0232255. PubMed ID: 32348375 [TBL] [Abstract][Full Text] [Related]
11. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density. Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628 [TBL] [Abstract][Full Text] [Related]
12. Relation of interdigitation zone changes and right-angle vessels in Macular Telangiectasia Type-2 (MacTel). Chandran K; Giridhar A; Gopalakrishnan M; Sivaprasad S Eye (Lond); 2023 Oct; 37(14):2977-2986. PubMed ID: 36841866 [TBL] [Abstract][Full Text] [Related]
13. MACULAR TELANGIECTASIA TYPE 2: Acircularity Index and Quantitative Assessment of Foveal Avascular Zone Using Optical Coherence Tomography Angiography. Ersoz MG; Hocaoglu M; Sayman Muslubas I; Arf S; Karacorlu M Retina; 2020 Jun; 40(6):1132-1139. PubMed ID: 30893277 [TBL] [Abstract][Full Text] [Related]
15. Functional Relevance of Hyper-Reflectivity in Macular Telangiectasia Type 2. Tzaridis S; Friedlander M; Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):6. PubMed ID: 33661283 [TBL] [Abstract][Full Text] [Related]
16. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2. Ayachit AG; Reddy LU; Joshi S; Ayachit GS Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674 [TBL] [Abstract][Full Text] [Related]
17. Fundus Autofluorescence Imaging in Macular Telangiectasia Type 2: MacTel Study Report Number 9. Pauleikhoff L; Heeren TFC; Gliem M; Lim E; Pauleikhoff D; Holz FG; Clemons T; Balaskas K; ; Egan CA; Charbel Issa P Am J Ophthalmol; 2021 Aug; 228():27-34. PubMed ID: 33775659 [TBL] [Abstract][Full Text] [Related]
18. Characteristics and quantification of vascular changes in macular telangiectasia type 2 on optical coherence tomography angiography. Chidambara L; Gadde SG; Yadav NK; Jayadev C; Bhanushali D; Appaji AM; Akkali M; Khurana A; Shetty R Br J Ophthalmol; 2016 Nov; 100(11):1482-1488. PubMed ID: 26823394 [TBL] [Abstract][Full Text] [Related]
19. Retinal vascular density evaluated by optical coherence tomography angiography in macular telangiectasia type 2. Dogan B; Erol MK; Akidan M; Suren E; Akar Y Int Ophthalmol; 2019 Oct; 39(10):2245-2256. PubMed ID: 30607862 [TBL] [Abstract][Full Text] [Related]
20. CONE DENSITY LOSS ON ADAPTIVE OPTICS IN EARLY MACULAR TELANGIECTASIA TYPE 2. Jacob J; Krivosic V; Paques M; Tadayoni R; Gaudric A Retina; 2016 Mar; 36(3):545-51. PubMed ID: 26418443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]